Scarica l'app Stockscreener
16.94
0.95%
0.13
Nurix Therapeutics Inc Borsa (NRIX) Ultime notizie
(NRIX) as a Liquidity Pulse for Institutional Tactics - Stock Traders Daily
Insider Sell: Christine Ring Sells Shares of Nurix Therapeutics Inc (NRIX) - GuruFocus
Nurix Therapeutics CLO Christine Ring sells $90,406 in stock By Investing.com - Investing.com India
Nurix Therapeutics CLO Christine Ring sells $90,406 in stock - Investing.com
Nurix Therapeutics (NRIX) legal chief sells 5,394 shares in planned trade - Stock Titan
Issuer (NASDAQ: NRIX) reports proposed RSU sale by executive - Stock Titan
Nurix Therapeutics, Inc. (NASDAQ:NRIX) Given Consensus Recommendation of "Moderate Buy" by Brokerages - MarketBeat
Nurix Therapeutics (NASDAQ:NRIX) CFO Houte Hans Van Sells 2,388 Shares - MarketBeat
Insider Selling: Nurix Therapeutics (NASDAQ:NRIX) Insider Sells 3,214 Shares of Stock - MarketBeat
Nurix therapeutics CSO Hansen sells $53,497 common stock - Investing.com UK
Nurix therapeutics CSO Hansen sells $53,497 common stock By Investing.com - Investing.com India
Nurix therapeutics CFO Hans van Houte sells $39,748 in shares By Investing.com - Investing.com India
Nurix Therapeutics CLO Christine Ring sells $53,497 in shares By Investing.com - Investing.com Canada
Nurix Therapeutics CLO Christine Ring sells $53,497 in shares - Investing.com
Nurix (NRIX) CFO nets shares after RSU vesting tax sale - Stock Titan
Tax-driven share sale and RSU vesting for Nurix (NRIX) - Stock Titan
Nurix (NRIX) CSO Hansen converts RSUs, sells 3,214 shares to cover taxes - Stock Titan
Pictet Asset Management Holding SA Acquires 1,487,060 Shares of Nurix Therapeutics, Inc. $NRIX - MarketBeat
California Biopharma Co. Uncovers Massive Oncology Breakthrough - Streetwise Reports
Nurix Therapeutics shares edge higher despite Q1 earnings miss - MSN
Nurix Therapeutics (NRIX) Soars 5.6%: Is Further Upside Left in the Stock? - MSN
Institutional Investors Accumulate Nurix Therapeutics Stock on TPD Leadership - HarianBasis.co
Nurix Therapeutics Inc. (NRIX): Leadership in Targeted Protein Degradation Attracts Smart Money - Insider Monkey
NRIX Reiterated by HC Wainwright & Co. -- Price Target Maintained at $32 - GuruFocus
Nurix Therapeutics (NASDAQ:NRIX) Receives Buy Rating from HC Wainwright - MarketBeat
H.C. Wainwright reiterates Buy on Nurix stock, $32 target - Investing.com UK
H.C. Wainwright reiterates Buy on Nurix stock, $32 target By Investing.com - Investing.com Australia
Billionaire Joe Edelman’s 5 Stock Picks with Huge Upside Potential - Insider Monkey
Assessing Nurix Therapeutics (NRIX) Valuation After New AACR 2026 Oncology Data - Sahm
Redmile (NRIX) holds 10.7M shares — 9.9% including warrants - Stock Titan
Nurix Therapeutics (NRIX) Receives a Buy from Piper Sandler - The Globe and Mail
NRIX Price Today: Nurix Therapeutics, Inc. Stock Price, Quote & Chart | MEXC - MEXC Exchange
Does Nurix Therapeutics (NRIX) have the potential to rally 85.84% as Wall Street analysts expect? - MSN
NRIX Reiterates by Needham -- Price Target Maintained at $26 - GuruFocus
Needham & Company LLC Reiterates Buy Rating for Nurix Therapeutics (NASDAQ:NRIX) - MarketBeat
(NRIX) Risk Channels and Responsive Allocation - Stock Traders Daily
Nurix Therapeutics Announces New Preclinical Data Highlighting Breadth of Targeted Protein Degradation Pipeline at AACR 2026 - The Manila Times
In preclinical brain metastasis model, Nurix drug lifted lifespan 142% - Stock Titan
Nurix presents preclinical oncology data at AACR meeting - Investing.com
Follicular Lymphoma Clinical Trial Space Intensifies with 45+ Companies in Active Development | DelveInsight - GlobeNewswire Inc.
Analyst Firms Adjust Nurix Therapeutics Price Targets Following Financial Reports - HarianBasis.co
Nurix (NRIX) Stock: Smart Money Signals (-2.34%) 2026-04-20Professional Trade Ideas - Cổng thông tin điện tử Tỉnh Sơn La
Wells Fargo Cuts PT on Nurix Therapeutics (NRIX) to $28 From $29 - Insider Monkey
Nurix Therapeutics (NRIX) Is Up 9.2% After Reporting Sharply Lower Q1 Revenue And Wider Loss - Sahm
5 Best Low Priced Biotech Stocks to Invest In - Insider Monkey
1.17%
3.22%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):